In the News

For press inquiries: teamritedose@mcalistercommunications.com

Ritedose, South Carolina’s Leading Pharmaceutical Manufacturer, Buys 105 Acres of Land for Major Expansion.
50-percent growth in pharmaceutical manufacturing and sales spurs expansion, job creation

Columbia, S.C. (February 22, 2024) — The Ritedose Corporation (Ritedose) today announced a major expansion of its rapidly-growing pharmaceutical company with the recent purchase of 105 acres from the Midlands Technical College Enterprise Campus in Richland Northeast.

Read More »

Ritedose Pharmaceuticals Launches Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml)

COLUMBIA, S.C. (August 24, 2023) – Ritedose, a pharmaceutical manufacturer located in South Carolina, launched a new sterile unit dose generic product, Cromolyn Sodium Inhalation Solution, USP (20 mg/2 ml). The single-dose vial product joins a range of other inhalation solutions produced by Ritedose Pharmaceuticals and is available in cartons of 60 vials. Ritedose Pharmaceuticals is a division of The Ritedose Corporation, a 27-year-leader in cGMP drug manufacturing for major pharmaceutical companies, research development programs, hospitals, wholesalers and pharmacies.

Read More »

Ritedose Launches Albuterol Sulfate Inhalation Solution 0.5% (5 mg/mL) to Meet National Drug Shortage

COLUMBIA, S.C. (May 9, 2023) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose vial product, Albuterol Sulfate Inhalation Solution 0.5% (5 mg/mL). It is a ready-to-use drug shortage solution for hospital pharmacies across the country. Ritedose is a division of The Ritedose Corporation, a 27-year-leader in cGMP drug manufacturing for major pharmaceutical companies and research development programs.

Read More »

Ritedose Pharmaceuticals Launches New Product: Arformoterol Tartrate Inhalation Solution (15 mcg/2 ml)

COLUMBIA, S.C. (April 13, 2023) – Ritedose, a pharmaceutical manufacturer located in South Carolina, just launched a new single unit dose oral inhalation product, Arformoterol Tartrate (15 mcg/2 ml), making the company the largest generic drug maker of its kind. Ritedose Pharmaceuticals is a division of The Ritedose Corporation, a 25-year-leader in cGMP drug manufacturing for major pharmaceutical companies, research development programs, hospitals, wholesalers and pharmacies.

Read More »

Ritedose Awarded 503B Compounded Medications Agreement with Premier, Inc.

COLUMBIA, S.C. (January 30, 2023) – Ritedose, a 503B outsourcing facility located in South Carolina, has been awarded a group purchasing agreement with Premier Inc., a leading healthcare improvement company operating one of the nation’s largest group purchasing organizations (GPOs). Effective January 1, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Ritedose’s full range of compounded medications.

Read More »

Ritedose Launches Two New Single-Dose Syringe Products Amid National Drug Shortage: Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL)

COLUMBIA, S.C. (November 17, 2022) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched two new unit dose syringe products, Bupivacaine Hydrocholoride 0.25% (2.5 mg/mL) and Bupivacaine Hydrocholoride 0.5% (5 mg/mL). They are ready-to-use drug shortage solutions for hospital pharmacies across the country. Ritedose is a division of The Ritedose Corporation, a 27-year-leader in cGMP drug manufacturing for major pharmaceutical companies and research development programs.

Read More »

Ritedose Launches Critical Single-Dose Syringe Product Amid National Drug Shortage: Lidocaine Hydrochloride 1% 100 mg/10 mL

COLUMBIA, S.C. (October 17, 2022) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Lidocaine Hydrochloride 1% 100 mg/10 mL. It is a ready-to-use drug shortage solution for hospital pharmacies across the country. Ritedose is a division of The Ritedose Corporation, a 27-year-leader in cGMP drug manufacturing for major pharmaceutical companies and research development programs.

Read More »

Pioneers in aseptic production of sterile, single-dose medication